SCHEMBL19625006

SCHEMBL19625006

N#Cc1cccc2[nH]c(C(=O)N=N)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 2/20 0.39
KDM4E B2RXH2 4/20 0.35
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
CYP1A2 P05177 1/20 0.35
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
AHR P35869 1/20 0.35
CHRNA7 P36544 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19625008 0.87 SLC9A1 (0.39) SLC9A1KDM4EALDH1A1HSD17B10KMT2A
SCHEMBL15506643 0.82 KDM4E (0.53) KDM4EALDH1A1HSD17B10KMT2AMEN1
SCHEMBL29063172 0.81 SLC9A1 (0.41) SLC9A1KDM4EALDH1A1HSD17B10KMT2A
SCHEMBL19625090 0.78 FLT3 (0.53) SLC9A1KDM4EALDH1A1HSD17B10KMT2A
SCHEMBL22620591 0.77 KIF11 (0.43) KDM4EALDH1A1HSD17B10KMT2AMEN1
SCHEMBL25758852 0.74 MEN1 (0.51) KDM4EALDH1A1KMT2AMEN1GAA
SCHEMBL15506670 0.74 ALDH1A1 (0.51) KDM4EALDH1A1HSD17B10KMT2AMEN1
SCHEMBL19624948 0.70 HTR6 (0.39) KDM4EALDH1A1HSD17B10KMT2AMEN1
SCHEMBL3392115 0.70 DAO (0.59) KDM4EALDH1A1MAPT
SCHEMBL28577661 0.70 NR3C1 (0.41) KDM4EALDH1A1HSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2892880-B1 INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF NOVARTIS AG (CH) 2017-11-22 EP disclosed